ATL is a company hitting on all cylinders, if one doesn't countthe legal arena. The Bothell, WA, ultrasound vendor this monthreported financial results for its third quarter (end-September)that show revenues and net income growing at a healthy pace.
ATL is a company hitting on all cylinders, if one doesn't countthe legal arena. The Bothell, WA, ultrasound vendor this monthreported financial results for its third quarter (end-September)that show revenues and net income growing at a healthy pace.
For the period, ATL posted revenues of $100.3 million, up 6%compared with $94.7 million in the third quarter of 1995. Netincome rose to $3.8 million, compared with a net loss of $742,000last year, when ATL took a one-time charge. The company's grossmargin rose to a record 49.1%, compared with 46.1% in the sameperiod last year.
ATL said both its HDI 3000 and Apogee 800 Plus scanners wereturning in strong sales. The company's revenue growth suggeststhat arch-rival Acuson's gains with its Sequoia platform are notcoming at ATL's expense. Sequoia sales were the engine behinda 24% increase in Acuson revenues (see story, page 1).
ATL's year-to-date profit numbers are not quite so rosy, however,due to a massive $29.6 million charge taken earlier this yearto pay for an unfavorable judgment in patent litigation with SRIInternational (SCAN 7/31/96). ATL is appealing the ruling.
For the first nine months of 1996, ATL has reported a net lossof $12.4 million on revenues of $293.7 million. This compareswith a net loss of $180,000 on sales of $280.4 million in thesame period a year ago.
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.